Page last updated: 2024-08-21

lithium carbonate and reboxetine

lithium carbonate has been researched along with reboxetine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, T; Izumi, T; Kitaichi, Y; Koyama, T; Nakagawa, S	1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J	1
Domenici, E; Ieraci, A; Musazzi, L; Popoli, M; Racagni, G; Rimland, JM	1

Trials

1 trial(s) available for lithium carbonate and reboxetine

Article	Year
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid	2007

Article

Year

Motor cortex excitability after vagus nerve stimulation in major depression.

Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid

2007

Other Studies

2 other study(ies) available for lithium carbonate and reboxetine

Article	Year
Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats. European journal of pharmacology, 2004, Apr-12, Volume: 489, Issue:3 Topics: Administration, Oral; Animals; Dopamine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Extracellular Space; Injections, Intraperitoneal; Lithium Carbonate; Male; Morpholines; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin	2004
Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:5 Topics: Adrenergic Agonists; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Fluoxetine; Hippocampus; Lithium Carbonate; Morpholines; Neurons; Norepinephrine; Promoter Regions, Genetic; Rats; Reboxetine; Serotonin; Serotonin Receptor Agonists; Transcriptional Activation	2014

Article

Year

Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats.

European journal of pharmacology, 2004, Apr-12, Volume: 489, Issue:3

Topics: Administration, Oral; Animals; Dopamine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Extracellular Space; Injections, Intraperitoneal; Lithium Carbonate; Male; Morpholines; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin

2004

Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation.

The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:5

Topics: Adrenergic Agonists; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Fluoxetine; Hippocampus; Lithium Carbonate; Morpholines; Neurons; Norepinephrine; Promoter Regions, Genetic; Rats; Reboxetine; Serotonin; Serotonin Receptor Agonists; Transcriptional Activation

2014